Skip to main content
Premium Trial:

Request an Annual Quote

Oxford, Oracle Partner to Improve Identification of SARS-CoV-2 Variants

NEW YORK – Oracle said Sunday that it is teaming with the University of Oxford to create a technology platform to accelerate the identification of SARS-CoV-2 variants.

Called the Global Pathogen Analysis System, or GPAS, the platform combines the UK university's Scalable Pathogen Pipeline Platform, or SP3, with the Oracle Cloud Infrastructure to standardize, analyze, compare, and annotate SARS-CoV-2 sequencing data in search of novel variants that could undermine vaccine efficacy and prolong the COVID-19 pandemic.

The partnership builds on earlier work, funded by the Wellcome Trust, that involved Public Health Wales, the University of Cardiff, and Public Health England, and finds a new use for SP3, which had been developed to track tuberculosis outbreaks. The addition of the Oracle Cloud enhances SP3 processing power, security, and global collaboration, according to the Austin, Texas-based firm.

"The enhanced SP3 system will establish a global standard for pathogen data gathering and analysis, thus enabling medical researchers to better understand the COVID-19 virus and other microbial threats to public health," said Larry Ellison, Oracle chairman and CTO, in a statement.

"This powerful new tool will enable public health scientists in research establishments, public health agencies, healthcare services, and diagnostic companies around the world to help further understanding of infectious diseases, starting with the coronavirus," Derrick Crook, professor of microbiology in Oxford's Nuffield Department of Medicine, said in a statement.

"The Global Pathogen Analysis System will help to establish a global common standard for assembling and analyzing this new virus, as well as other microbial threats to public health. This adds a new dimension in our ability to process pathogen data," Crook added.

Oxford and Oracle said that they eventually plan on extending GPAS to all pathogens. The platform will be available for free to researchers and nonprofits worldwide.

The Scan

Tara Pacific Expedition Project Team Finds High Diversity Within Coral Reef Microbiome

In papers appearing in Nature Communications and elsewhere, the team reports on findings from the two-year excursion examining coral reefs.

Study Examines Relationship Between Cellular Metabolism, DNA Damage Repair

A new study in Molecular Systems Biology finds that an antioxidant enzyme shifts from mitochondria to the nucleus as part of the DNA damage response.

Stem Cell Systems Target Metastatic Melanoma in Mouse Model

Researchers in Science Translational Medicine describe a pair of stem cell systems aimed at boosting immune responses against metastatic melanoma in the brain.

Open Pediatric Brain Tumor Atlas Team Introduces Genomic Data Collection, Analytical Tools

A study in Cell Genomics outlines open-source methods being used to analyze and translate whole-genome, exome, and RNA sequence data from the Pediatric Brain Tumor Atlas.